Neogenomics (NEO) Change in Inventory (2010 - 2026)

Neogenomics (NEO) has 17 years of Change in Inventory data on file, last reported at -$2.7 million in Q2 2026.

• Quarterly Change in Inventory fell 165.49% year-over-year to -$2.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$7.0 million (down 165.85% YoY) and the FY2025 annual result came in at $1.5 million, down 42.83% from the prior year.
• Change in Inventory eased to -$2.7 million in Q2 2026, from $1.3 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $4.1 million in Q2 2025 to a low of -$5.6 million in Q3 2025.
• A 5-year average of $242611.1 and a median of $566500.0 in 2022 frame the typical range for Change in Inventory.
• The widest YoY moves for Change in Inventory: up 1034.16% in 2024, down 2018.0% in 2024.
• Tracing NEO's Change in Inventory over 5 years: stood at $697000.0 in 2022, then tumbled by 71.02% to $202000.0 in 2023, then soared by 1034.16% to $2.3 million in 2024, then tumbled by 98.78% to $28000.0 in 2025, then sank by 9742.86% to -$2.7 million in 2026.
• The last three Change in Inventory figures came in at -$2.7 million (Q2 2026), $1.3 million (Q1 2026), and $28000.0 (Q4 2025), per Business Quant data.